Advisory Board

Neurolixis is gathering a world-class Advisory Board to assist in advancing its projects rigorously and effectively. It includes researchers with detailed knowledge of psychiatric and neurological disorders and of pharmaceutical industry drug development strategy.


Prof. Francesc Artigas, PhD

Prof. Artigas (Barcelona, Spain) is recognized as one of the foremost pioneers in the investigation of the mechanism of action of antidepressant and antipsychotic drugs, with particular interest in the role of neurotransmitters in brain areas controlling mood and cognition. More...


Dr. Mark H.N. Corrigan, MD

Dr. Corrigan (Boston, USA) has profound understanding of drug develoment and clinical trials strategy in the pharmaceutical and biotechnology environment. He has extensive management experience in several large pharmaceutical companies  More...


Prof. Daniel Hoyer, PhD, DSc, FBPharmacolS

Prof. Hoyer (Melbourne, Australia) has combined highly-cited fundamental research in receptor pharmacology with industrial drug discovery in pharmaceutical companies. He has detailed knowlege of the challenges facing target validation and drug development  More...